The history of Sildenafil presents a complex case for investors in the drug sector. While initially a phenomenal success, producing vast sums, the intellectual property lapse and the subsequent flood of generic alternatives have significantly affected revenue. This raises questions about the long-term sustainability of related medication innovat… Read More